相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice
Ting Zhang et al.
ENDOCRINOLOGY (2016)
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Karin Avall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
Giuseppe Danilo Norata et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Differential responses of pancreatic β-cells to ROS and RNS
Gordon P. Meares et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Chutima Talchai et al.
CELL (2012)
Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Apolipoprotein CIII Reduces Proinflammatory Cytokine-Induced Apoptosis in Rat Pancreatic Islets via the Akt Prosurvival Pathway
Joachim Storling et al.
ENDOCRINOLOGY (2011)
Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance
Julia Kozlitina et al.
HEPATOLOGY (2011)
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN
Wen Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lipid parameters for measuring risk of cardiovascular disease
Benoit J. Arsenault et al.
NATURE REVIEWS CARDIOLOGY (2011)
Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
Kitt Falk Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Glucolipotoxicity:: Fuel excess and β-cell dysfunction
Vincent Poitout et al.
ENDOCRINE REVIEWS (2008)
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice
Adama Kamagate et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword?
Jyoti D. Malhotra et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis
Dongming Su et al.
DIABETES (2007)
Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice
Shen Qu et al.
JOURNAL OF LIPID RESEARCH (2007)
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics
DC Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression
G Gerritsen et al.
JOURNAL OF LIPID RESEARCH (2005)
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
JS Cohn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
J Altomonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes
RP Robertson
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Coronary artery disease risk in familial combined - Hyperlipidemia and familial hypertriglyceridemia - A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study
PN Hopkins et al.
CIRCULATION (2003)
The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat
DJ Nieves et al.
DIABETES (2003)
ApoC-III gene polymorphisms and risk of coronary artery disease
O Olivieri et al.
JOURNAL OF LIPID RESEARCH (2002)
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes
GF Lewis et al.
ENDOCRINE REVIEWS (2002)
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity -: The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study
JM Bard et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia
N Kubota et al.
DIABETES (2000)
分享论文
